Clinical Trial Update: Safety and Efficacy Study in Subjects With Seborrheic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study in seborrheic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Snippet

Sponsor: Medicis Global Service Corporation | Conditions: Seborrheic Dermatitis | Phase 2 | Status: COMPLETED